Department of Medicine  
Introduction   |   Research   |   Recent Publications   |   Patient Care   |   Faculty Profiles   |   Related Links   |   Give to Cardiology   |   Contact Us   |   Home


 
Allen Jeremias, MD, MSc


 

Allen Jeremias, MD, MSc
Assistant Professor of Medicine
Director, Vascular Medicine and Peripheral Intervention

Division of Cardiovascular Medicine
SUNY-Stony Brook
Health Sciences Center T16-080
Stony Brook, NY 11794
Phone: 631-444-1064
Fax: 631-444-1054

EDUCATION AND TRAINING

  • B.A. Semmelweis University School of Medicine, Budapest Hungary, 1990
  • M.D., Heinrich-Heine University School of Medicine, Dusseldorf, Germany, 1995
  • M.Sc., Clinical Investigator Training Program, Harvard Medical School and Massachusetts Institute of Technology, 2003-2005.
  • Research Fellowship, Division of Cardiovascular Medicine, Stanford University, Stanford, CA, 1997-1999
  • Resident, Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, 1999-2002.
  • Fellow, Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2002-2005
  • Fellow, Interventional Cardiology/Peripheral Vascular Fellowship, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2004-2006.

BOARD CERTIFICATION

  • American Board of Internal Medicine, 2002
  • American Board of Cardiovascular Medicine, 200
  • American Board of Interventional Cardiology, 200
  • American Board of Vascular Medicine, 2006

AREAS OF CLINICAL EXPERTISE

  • Interventional cardiology
  • Peripheral vascular intervention
  • Vascular medicine
  • Aortic valve stenosis

CURRENT RESEARCH INTERESTS

  • Outcomes research in cardiovascular disease
  • Diagnosis and treatment of peripheral arterial disease
  • Coronary hemodynamics

SPECIAL ACCOMPLISHMENTS/RECENT PUBLICATIONS

  • Castle Connolly Top Doctors: New York Metro Area, 2009
  • Cardiovascular Research Technologies (CRT) Young Leadership Award, 2009
  • Marquis’s Who’s Who of Emerging Leaders, 2007
  • Strathmore’s Who’s Who, 2002
  • Doctoral Thesis honored with “magna cum laude”, 1996
  • Jeremias A , Kolz ML, Ikonen TS, Gummert JF, Oshima A, Hayase M, Honda Y, Komiyama N, Berry GJ, Morris RE, Yock PG, Fitzgerald PJ. Feasibility of in vivo intravascular ultrasound tissue characterization in the detection of early vascular transplant rejection. Circulation 1999; 100:2127-2130.
  • Jeremias A , Filardo SD, Whitbourn RJ, Kernoff RS, Yeung AC, Fitzgerald PJ, Yock PG. Effects of intravenous and intracoronary adenosine 5'-triphosphate as compared to adenosine on coronary flow and pressure dynamics. Circulation 2000; 101:318-323.
  • Jeremias A , Huegel H, Lee DP, Hassan A, Wolf A, Yeung AC, Yock PG, Fitzgerald PJ. Spatial orientation of atherosclerotic plaque in non-branching coronary artery segments. Atherosclerosis 2000; 152:209-215.
  • Jeremias A , Spies C, Herity NA, Pomerantsev E, Yock PG, Fitzgerald PJ, Yeung AC. Coronary artery compliance and adaptive vessel remodeling in patients with stable and unstable coronary artery disease. Heart 2000; 84:314-319.
  • Ward MR, Jeremias A, Huegel H, Fitzgerald PJ, Yeung AC. Accentuated remodeling on the upstream side of atherosclerotic lesions. Am J Cardiol 2000; 85:523-526.
  • Jeremias A , Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, Tuzcu EM, Anderson WD, Abizaid AA, Mintz GS, Yeung AC, Kern MJ, Yock PG. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J 2000; 140:651-657.
  • Jeremias A , Bertschat FL, Jeremias E, Ising H. Possible correlation between decrease of ionized magnesium and calcium in blood to patient outcome after acute myocardial infarction. J Clin Basic Cardiol 2000;3:123-128.
  • Fearon WF, Takagi A, Jeremias A, Cohen DJ, Chou T, Joye J, Yeung AC, Kern MJ, Yock PG. Use of fractional flow reserve to assess the functional significance of intermediate coronary stenoses. Am J Cardiol 2000; 86:1013-1014.
  • Ward MR, Jeremias A, Hibi K, Herity NA, Lo ST, Filardo SD, Lee DP, Fitzgerald PJ, Yeung AC. The influence of plaque orientation (pericardial or myocardial) on coronary arterial remodeling. Atherosclerosis 2001; 154:197-183.
  • Ward MR, Smits P, Herity NA, Jeremias A, Fitzgerald PJ, Yeung AC, de Jaegere P, Serruys PW, Pasterkamp G. No relationship between compensatory arterial remodeling of focal stenotic atherosclerotic lesions and tortuosity of the arterial segment involved. Atheroscl Thromb Vasc Biol 2001; 21:1383.
  • Jeremias A, Spies C, Herity NA, Ward MR, Pomerantsev E, Yock PG, Fitzgerald PJ, Yeung AC. Coronary artery distensibility and compensatory vessel enlargement - A novel parameter influencing vascular remodeling? Basic Res Cardiol 2001, 96:506-512.
  • Schoenhagen P, Vince DG, Ziada KM, Tsutsui H, Jeremias A, Crowe TD, Nissen SE, Tuzcu EM. Association of arterial expansion (expansive remodeling) of bifurcation lesions determined by intravascular ultrasonography with unstable clinical presentation. Am J Cardiol 2001, 88:785-787.
  • Fearon WF, Luna J, Samady H, Powers ER, Feldman T, Dib N, Tuzcu EM, Cleman MW, Chou TM, Cohen DJ, Ragosta M, Takagi A, Jeremias A, Fitzgerald PJ, Yeung AC, Kern MJ, Yock PG. Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment. Circulation 2001; 104:1917- 1922.
  • Jeremias A , Bhatt DL, Chew DP, Ziada KM, Albirini A, Brener SJ, Lincoff AM, Topol EJ, Ellis SG. Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency. Am J Cardiol 2002; 89: 1209-1211.
  • Jeremias A , Albirini A, Ziada KM, Chew DP, Brener SJ, Topol EJ, Ellis SG. Prognostic significance of creatine kinase-MB elevation following percutaneous coronary intervention in patients with chronic renal dysfunction. Am Heart J 2002; 143:1040-1045.
  • Jeremias A , Dusa C, Forudi F, Jacobsen DW, Vince DG, Nissen SE, Tuzcu EM. N-Acetyl-Cysteine in the prevention of vascular restenosis after percutaneous balloon angioplasty. Int J Cardiol 2004; 95:255-60.
  • Jeremias A , Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, Ho KKL, Cohen DJ, Cutlip DE, Carrozza JP. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004; 109:1930-32.
  • Jeremias A , Baim DS, Ho KKL, Chauhan M, Carrozza JP, Cohen DJ, Popma JJ, Kuntz RE, Cutlip DE. Differential mortality risk of post-procedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol 2004; 44:1210-4.
  • Hibi K, Ward MR, Honda Y, Suzuki T, Jeremias A, Okura H, Hassan AH, Maehara A, Yeung AC, Pasterkamp G, Fitzgerald PJ, Yock PG. Impact of different definitions on the interpretation of coronary remodeling determined by intravascular ultrasound. Catheter Cardiovasc Interv 2005; 65:233-9.
  • Jeremias A, Gibson CM. Alternative causes for elevated troponin levels when acute coronary syndromes are excluded. Ann Int Med 2005; 142:786-91.
  • Kirtane AJ, Rahman A, Martinezclark P, Jeremias A, Manning WJ. Survey of practice patterns in the management of anticoagulation in patients with mechanical valves undergoing elective outpatient procedures. Am J Cardiol 2006; 97:891-3.
  • Kumar R, Lee TT, Jeremias A, Ruisi CP, Sylvia B, Magallon J, Kirtane AJ, Bigelow B, Abrahamson M, Pinto DS, Ho KK, Cohen DJ, Carrozza JP Jr, Cutlip DE. Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients. Am J Cardiol 2007; 100:1187-91.
  • Jeremias A, Ruisi CP, Kirtane AJ, Lee T, Sylvia B, Pinto DS, Ho KKL, Cutlip DE, Carrozza JP Jr., Cohen DC. Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the “real world”. Coron Artery Dis 2008; 19:111-5.
  • Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DC. Prevalence and prognostic significance of pre-procedure cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: Results from the EVENT registry. Circulation 2008; 118:632-8.
  • Jeremias A, Kirtane AJ. Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med 2008; 148:234-8
  • Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. The impact of revascularization on mortality in patients with non-acute coronary artery disease. Am J Med 2009; 122:152-61.

top


© 2006 Stony Brook
Site design: Academic Web Pages